Christine A. Carberry
Plus aucun poste en cours
Profil
Christine A.
Carberry worked as Vice President-Program & Alliance Management at Biogen, Inc. She then worked as Chief Operating Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she was VP-Technical Operations & Alliance Management at FORUM Pharmaceuticals, Inc. from 2014 to 2016.
Carberry holds a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.
Anciens postes connus de Christine A. Carberry
Sociétés | Poste | Fin |
---|---|---|
KERYX BIOPHARMACEUTICALS | Directeur des opérations | 12/12/2018 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | 01/05/2016 |
BIOGEN INC. | Corporate Officer/Principal | - |
Formation de Christine A. Carberry
Boston University | Graduate Degree |
University of New Hampshire | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |